Straumann announces change in Board of Directors and Compensation Committee

Stefan Meister has asked the Board of Directors of Straumann Holding AG to release him from his responsibilities as a Member of the Board and Chairman of the Compensation Committee with immediate effect, owing to an illness in his family.

Stefan Meister has served on the Board since 2010 and has chaired the Compensation Committee for the past 6 years. To fill the gap created by his resignation, the Board has appointed Ulrich Looser as Chairman of the Compensation Committee and Dr h.c. Thomas Straumann as the third member of the Committee alongside Dr Beat Luethi. These appointments are in accordance with Article 3.2.6 of the Articles of Association and have immediate effect until the next General Meeting of the Shareholders on 7 April 2017.

Gilbert Achermann, Chairman of the Board, commented: "On behalf of the shareholders and everyone at Straumann I would like to wish Stefan Meister and his family all the best for the future. I would also like to thank him sincerely for his many valuable insights and contributions to the governance and sustained success of Straumann over the past 6 years."

About Straumann

Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately 3500 people worldwide and its products and services are available in more than 100 countries through its broad network of distribution subsidiaries and partners.